TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive House Preserves Funds For Space Station; Cancer Societies Reiterate Support For $170 Million Increase For NCI August 7, 1992